Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Recommends Final Dividend

Tuesday, 14 May 2013 04:14am EDT 

Dr.Reddy's Laboratories Ltd announced that the Board of Directors at its meeting held on May 14, 2013 has recommended a final dividend of INR15 (300%) per equity share of INR5 face value, for the financial year 2012-2013. 

Company Quote

53.05 +2.00%
11 Jul 2014